Original article| Volume 12, ISSUE 1, P11-20, January 2016

Long-term outcomes after Roux-en-Y gastric bypass: 10- to 13-year data



      Short- and mid-term data on Roux-en-Y gastric bypass (RYGB) indicate sustained weight loss and improvement in co-morbidities. Few long-term studies exist, some of which are outdated, based on open procedures or different techniques.


      To investigate long-term weight loss, co-morbidity remission, nutritional status, and complication rates among patients undergoing RYGB.


      An academic, university hospital in the United States.


      Between October 2000 and January 2004, patients who underwent RYGB≥10 years before study onset were eligible for chart review, office visits, and telephone interviews. Revisional surgery was an endpoint, ceasing eligibility for study follow-up. Outcomes included weight loss measures and rates of co-morbidity remission, complications, and nutritional deficiencies.


      RYGB was performed in 328 patients with a mean preoperative body mass index of 47.5 kg/m2. Of 294 eligible patients, 134 (46%) were contacted for follow-up at≥10 years (10+Year follow-up). Mean percentage excess weight loss (%EWL) was 58.9% at 10+Year. Higher %EWL was achieved by non–super-obese versus super-obese (61.3% versus 52.9%, P = .034). Blood pressure, lipid panel, and hemoglobin A1c improved significantly. At 10 years, remission of co-morbidities was 46% for hypertension and hyperlipidemia and 58% for diabetes mellitus. Thirty patients (9%) had revisional surgery for weight regain. Sixty-four patients (19.5%) had long-term complications requiring surgery. All-cause mortality was 2.7%. Nutritional deficiencies were seen in 87% of patients.


      Weight loss after RYGB appears to be significant and sustainable, especially in the non–super-obese. Co-morbidities are improved, with a substantial number in remission a decade later. Nutritional deficiencies are almost universal.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery for Obesity and Related Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Wittgrove A.C.
        • Clark G.W.
        Laparoscopic gastric bypass, Roux-en-Y—500 patients: technique and results, with 3–60 month follow-up.
        Obes Surg. 2000; 10: 233-239
        • Carlin A.M.
        • Zeni T.M.
        • English W.J.
        • et al.
        The comparative effectiveness of sleeve gastrectomy, gastric bypass, and adjustable gastric banding procedures for the treatment of morbid obesity.
        Ann Surg. 2013; 257: 791-797
        • Chang S.H.
        • Stoll C.R.
        • Song J.
        • Varela J.E.
        • Eagon C.J.
        • Colditz G.A.
        The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012.
        JAMA Surg. 2014; 149: 275-287
        • Schauer P.R.
        • Burguera B.
        • Ikramuddin S.
        • et al.
        Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus.
        Ann Surg. 2003; 238: 467-484
        • Kim S.
        • Richards W.O.
        Long-term follow-up of the metabolic profiles in obese patients with type 2 diabetes mellitus after Roux-en-Y gastric bypass.
        Ann Surg. 2010; 251: 1049-1055
        • Pories W.J.
        • Swanson M.S.
        • MacDonald K.G.
        • et al.
        Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus.
        Ann Surg. 1995; 222: 339-350
        • Edholm D.
        • Svensson F.
        • Näslund I.
        • Karlsson F.A.
        • Rask E.
        • Sundbom M.
        Long-term results 11 years after primary gastric bypass in 384 patients.
        Surg Obes Relat Dis. 2013; 9: 708-713
        • Christou N.V.
        • Look D.
        • Maclean L.D.
        Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years.
        Ann Surg. 2006; 244: 734-740
        • Valezi A.C.
        • de Almeida Menezes M.
        • Mali Jr, J.
        Weight loss outcome after Roux-en-Y gastric bypass: 10 years of follow-up.
        Obes Surg. 2013; 23: 1290-1293
        • MacDonald Jr, K.G.
        • Long S.D.
        • Swanson M.S.
        • et al.
        The gastric bypass operation reduces the progression and mortality of noninsulin-dependent diabetes mellitus.
        J Gastrointest Surg. 1997; 1: 213-220
        • Angrisani L.
        • Cutolo P.P.
        • Formisano G.
        • Nosso G.
        • Vitolo G.
        Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 10-year results of a prospective, randomized trial.
        Surg Obes Relat Dis. 2013; 9: 405-413
        • Higa K.
        • Ho T.
        • Tercero F.
        • Yunus T.
        • Boone K.B.
        Laparoscopic Roux-en-Y gastric bypass: 10-year follow-up.
        Surg Obes Relat Dis. 2011; 7: 516-525
      1. American Heart Association [homepage on the Internet]. Dallas: The Association; 2014 [updated 2015 Apr 28; cited 2014 Jun 13]. Understanding blood pressure readings. Available from:

      2. Third Report of the National Cholesterol Education Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). NIH Publication No. 01-3670. May 2001.

      3. American Diabetes Association [homepage on the Internet]. Alexandria, VA: The Association; ca. 1995–2014 [updated 2014 Sep 22; cited 2014 Jun 13]. Diagnosing diabetes and learning about prediabetes. Available from:

        • Metropolitan Life
        1983 Metropolitan height and weight tables.
        Stat Bull Metrop Life Found. 1983; 64: 3-9
        • Robinson J.D.
        • Lupkiewicz S.M.
        • Palenik L.
        • Lopez L.M.
        • Ariet M.
        Determination of ideal weight for drug dosage calculations.
        Am J Hosp Pharm. 1983; 40: 1016-1019
        • Halverson J.D.
        • Koehler R.E.
        Gastric bypass: analysis of weight loss and factors determining success.
        Surgery. 1981; 90: 446-455
        • Biron S.
        • Hould F.S.
        • Lebel S.
        • et al.
        Twenty years of biliopancreatic diversion: what is the goal of the surgery?.
        Obes Surg. 2004; 14: 160-164
        • Aftab H.
        • Risstad H.
        • Sovik T.T.
        • et al.
        Five-year outcome after gastric bypass for morbid obesity in a Norwegian cohort.
        Surg Obes Relat Dis. 2014; 10: 71-78
        • Heneghan H.M.
        • Meron-Eldar S.
        • Brethauer S.A.
        • Schauer P.R.
        • Young J.B.
        Effect of bariatric surgery on cardiovascular risk profile.
        Am J Cardiol. 2011; 108: 1499-1507
        • Ikramuddin S.
        • Korner J.
        • Lee W.J.
        • et al.
        Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.
        JAMA. 2013; 309: 2240-2249
        • Jiménez A.
        • Casamitjana R.
        • Flores L.
        • Delgado S.
        • Lacy A.
        • Vidal J.
        GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese patients.
        Ann Surg. 2013; 257: 894-899
        • Khoo C.M.
        • Chen J.
        • Pamuklar Z.
        • Torquati A.
        Effects of Roux-en-Y gastric bypass or diabetes support and education on insulin sensitivity and insulin secretion in morbidly obese patients with type 2 diabetes.
        Ann Surg. 2014; 259: 494-501
        • Zhang N.
        • Maffei A.
        • Cerabona T.
        • Pahuja A.
        • Omana J.
        • Kaul A.
        Reduction in obesity-related co-morbidities: is gastric bypass better than sleeve gastrectomy?.
        Surg Endosc. 2013; 27: 1273-1280
        • Hallersund P.
        • Sjöström L.
        • Olbers T.
        • et al.
        Gastric bypass surgery is followed by lowered blood pressure and increased diuresis—long term results from the Swedish Obese Patients (SOS) study.
        PLoS One. 2012; 7: e49696
        • Sjöström L.
        • Lindroos A.K.
        • Peltonen M.
        • et al.
        Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.
        N Engl J Med. 2004; 351: 2683-2693
        • Koppman J.S.
        • Li C.
        • Gandsas A.
        Small bowel obstruction after laparoscopic Roux-en-Y gastric bypass: a review of 9,527 patients.
        J Am Coll Surg. 2008; 206: 571-584
        • Maggard M.A.
        • Shugarman L.R.
        • Suttorp M.
        • et al.
        Meta-analysis: surgical treatment of obesity.
        Ann Intern Med. 2005; 142: 547-559
        • Vix M.
        • Liu K.H.
        • Diana M.
        • D׳Urso A.
        • Mutter D.
        • Marescaux J.
        Impact of Roux-en-Y gastric bypass versus sleeve gastrectomy on vitamin D metabolism: short-term results from a prospective randomized clinical trial.
        Surg Endosc. 2014; 28: 821-826
        • DiGiorgi M.
        • Daud A.
        • Inabnet W.B.
        • et al.
        Markers of bone and calcium metabolism following gastric bypass and laparoscopic adjustable gastric banding.
        Obes Surg. 2008; 18: 1144-1148
        • Obinwanne K.M.
        • Fredrickson K.A.
        • Mathiason M.A.
        • Kallies K.J.
        • Farnen J.P.
        • Kothari S.N.
        Incidence, treatment, and outcomes of iron deficiency after laparoscopic Roux-en-Y gastric bypass: a 10-year analysis.
        J Am Coll Surg. 2014; 218: 246-252
        • Majumder S.
        • Soriano J.
        • Louie Cruz A.
        • Dasanu C.A.
        Vitamin B12 deficiency in patients undergoing bariatric surgery: preventive strategies and key recommendations.
        Surg Obes Relat Dis. 2013; 9: 1013-1019
        • Rowland M.L.
        Self-reported weight and height.
        Am J Clin Nutr. 1990; 52: 1125-1133
        • Gourash W.F.
        • Ebel F.
        • Lancaster K.
        • et al.
        Longitudinal Assessment of Bariatric Surgery (LABS): retention strategy and results at 24 months.
        Surg Obes Relat Dis. 2013; 9: 514-519